Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Malaria vectored vaccines and EPI co-administration trial
PACTR201402000749217Not yet recruiting
- Sponsor
- Jenner Institute
- Start
- Mar 2014
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of ChAd63 ME-TRAP and MVA ME-TRAP in malaria (4 arms), sponsored by Jenner Institute. Primary endpoint: Safety and reactogenicity. Planned start Mar 2014; status: not yet recruiting.
02
Drugs
ChAd63 ME-TRAPMVA ME-TRAP
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR201402000749217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201402000749217.